SCHEMBL21067651

SCHEMBL21067651

Nc1ncnc2c1ncn2[C@@H]1O[C@@H](CO[P@@](=O)(O)OC(=O)[C@@H](N)Cc2c[nH]c3ccccc23)[C@H](O)[C@H]1O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 7/20 0.60
P2RY2 P41231 3/20 0.60
SRC P12931 2/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
P2RX1 P51575 2/20 0.60
P2RX3 P56373 2/20 0.60
ALDH1A1 P00352 2/20 0.60
P2RX4 Q99571 1/20 0.60
P2RX2 Q9UBL9 1/20 0.60
TRPM2 O94759 2/20 0.58
TAS1R3 Q7RTX0 2/20 0.58
TAS1R1 Q7RTX1 2/20 0.58
DNPH1 O43598 1/20 0.58
PRKAB2 O43741 1/20 0.58
LDHA P00338 1/20 0.58
ADRB2 P07550 1/20 0.58
FBP1 P09467 1/20 0.58
ADORA1 P30542 1/20 0.58
PRKAG1 P54619 1/20 0.58
PRKAA2 P54646 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL15670577 0.91 P2RY1 (0.65) P2RY1P2RY2SRCSMN1; SMN2P2RX1
Adenosine Phosphate SCHEMBL2037385 0.91 P2RY1 (0.65) P2RY1P2RY2SRCSMN1; SMN2P2RX1
SCHEMBL11772880 0.91 MARS1 (0.62) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL225270 0.91 MARS1 (0.62) P2RY1P2RY2SRCSMN1; SMN2TRPM2
SCHEMBL4945718 0.86 P2RY1 (0.69) P2RY1P2RY2SRCSMN1; SMN2P2RX1
SCHEMBL30051599 0.86 P2RY1 (0.69) P2RY1P2RY2SRCSMN1; SMN2P2RX1
Adenosine Phosphate SCHEMBL15670433 0.86 P2RY1 (0.58) P2RY1P2RY2SRCSMN1; SMN2P2RX1
Adenosine SCHEMBL225271 0.84 INMT (0.61) SMN1; SMN2ADORA1INMT
Adenosine SCHEMBL225269 0.84 INMT (0.61) SMN1; SMN2ADORA1INMT
SCHEMBL11683092 0.84 HINT1 (0.54) ADORA1INMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed